Raleigh, NC – According to filings with the U.S. Securities and Exchange Commission, Advanced Chemotherapy Technologies is raising $14,100,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Anthony Voiers played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Advanced Chemotherapy Technologies

Advanced Chemotherapy Technologies is a privately held medical technology company focused on groundbreaking chemotherapy delivery solutions for cancers that are difficult to treat with systemic therapy alone. We are currently focusing on the technical design and development of a novel pancreatic cancer drug delivery device, preparing for first in human trials. Our lead product, ACT-IOP-003, is the first-in-class to combine iontophoresis drug delivery with an implantable delivery system to target drug delivery with laser-like precision.

To learn more about Advanced Chemotherapy Technologies, visit http://advancedchemotech.com/

Contact:
Anthony Voiers, Chief Executive Officer
919-917-7944
https://www.linkedin.com/in/tony-voiers-84a12231/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved